
Opinion|Videos|March 19, 2024
Complying with REMS Training and Documentation Requirements
Michael Singel, PharmD, discusses the logistics of complying with the Risk Evaluation and Mitigation Strategy program for bispecific antibodies at his institution and addresses training and documentation requirements.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Reduces Time in Spent in Hospital, Admission Rates in Patients With Overweight or Obesity
2
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
3
Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes
4
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
5


























